Cardiovascular Revascularization Medicine (CRM)

Cardiovascular Revascularization Medicine (CRM) is an international, English-language, multidisciplinary, peer-reviewed journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. CRM publishes 12 regular print issues and a supplemental issue each year. The journal is indexed on Index Medicus and MEDLINE/PubMed. The journal's location in Washington, DC, gives it an advantage in reporting on regulatory issues as they pertain to interventional cardiology and structural heart disease. The journal is read by cardiologists, interventional cardiologists, structural heart interventionalists, vascular physicians, healthcare regulators, industry, fellows in training, and innovators around the globe.

Cardiovascular Revascularization Medicine (CRM) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cardiology and Cardiovascular Medicine, The journal is read by cardiologists, interventional cardiologists, structural heart interventionalists, vascular physicians, healthcare regulators, industry, fellows in training, innovators around the globe , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1553-8389, E-ISSN: 1878-0938, Established: 2005, Impact Factor: 2.1
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE